Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
Solutions designed to help clinicians reduce administrative burden, improve diagnostic accuracy, and spend more time with patients
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
PMDA is regarded among the most stringent regulatory bodies globally
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
_Limited_256_384.jpg)
Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
